Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov |
Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby |
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
1. Effective Date of Registration | 7/1/2024 |
||||
2. House Identification | 56560 |
Senate Identification | 401108688 |
REGISTRANT Organization/Lobbying Firm Self Employed Individual
3. Registrant | Organization | AEGIS LLC |
Address | 1177 22nd Street NW |
Address2 | Unit 4A |
City | Washington |
State | DC |
Zip | 20037 |
Country | USA |
4. Principal place of business (if different than line 3)
City |
|
State |
|
Zip |
|
Country |
|
5. Contact name and telephone number | International Number |
Contact | Mrs. Beth Anne Cole |
Telephone | 3019284388 |
bethannec@gmail.com |
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
7. Client name | Pharmaceutical Research and Manufacturers of America |
Address | 950 F Street NW, Suite 300 |
City | Washington |
State | DC |
Zip | 20004 |
Country | USA |
City |
|
State |
|
Zip |
|
Country |
|
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
Name | Covered Official Position (if applicable) | ||
First |
Last |
Suffix |
|
Anne | Esposito | | Health Policy Coordinator, Energy and Commerce Committee; Health Policy Advisor, Health Subcommittee (Chairman Bilirakis) |
| | | |
| | | |
| | | |
| | | |
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
PHA |
HCR |
|
|
|
|
|
|
|
12. Specific lobbying issues (current and anticipated)
PBM reforms. 340B. IRA implementation. Drug pricing. General health care issues.
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. |
Internet Address: |
|
Name | Address | Principal Place of Business | ||||||||
Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. |
Address | Ownership | |||||
Name | Street | Principal place of business | Amount of contribution | |||
|
(city and state or country) | for lobbying activities |
|
|
|||||||||||
|
|
|
|
|
% | |||||||
|
|
|||||||||||
|
|
|
|
|
% |
CONVICTIONS DISCLOSURE
15. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Signature | Digitally Signed By: Beth Anne Cole |
Date | 7/23/2024 12:40:24 PM |